精氨酸酶在皮肤上皮分化及抗菌肽产生中的作用
本研究探讨精氨酸酶1(ARG1)在角质形成细胞分化和抗菌反应中的作用。体外实验显示抑制ARG1会降低丝聚蛋白、外皮蛋白等晚期分化标志物及抗菌肽表达,补充腐胺和尿素可逆转此效应。离体特应性皮炎模型中ARG1表达下调,提示调控ARG1通路可能用于特应性皮炎管理。
要点
- ARG1在人表皮顶层高表达,与角质形成细胞晚期分化相关。
- 抑制ARG1降低丝聚蛋白、外皮蛋白、兜甲蛋白及抗菌肽表达。
- 补充腐胺或尿素可挽救ARG1缺陷细胞的晚期分化和抗菌肽表达。
核心结论
- ARG1活性在角质形成细胞分化和抗菌肽产生中起主要作用。
- ARG1在特应性皮炎离体模型中表达下调,其功能可通过下游产物腐胺和尿素挽救。
- 调控ARG1通路可能用于特应性皮炎等皮肤疾病的管理。
研究设计与样本
- 采用体外二维分化实验,使用ARG敲低或ARG抑制的角质形成细胞。
- 在离体特应性皮炎模型中评估ARG1表达。
主要发现
- ARG1在人皮肤顶层强烈表达,对应于晚期分化角质形成细胞中的高表达。
- 离体特应性皮炎模型中ARG表达较对照下调。
- 抑制ARG1导致晚期分化标志物丝聚蛋白、外皮蛋白和兜甲蛋白显著减少,抗菌肽、脂质运载蛋白2、激肽释放酶及富含脯氨酸小蛋白显著下调。
- 补充ARG产物腐胺和尿素可挽救ARG缺陷细胞的晚期角质形成细胞分化和抗菌肽表达。
关键数值与推荐
- ARG1抑制后丝聚蛋白、外皮蛋白和兜甲蛋白显著下降。
- ARG1抑制后抗菌肽、脂质运载蛋白2、激肽释放酶及富含脯氨酸小蛋白显著下调。
- 补充腐胺或尿素可挽救ARG缺陷细胞的晚期分化和抗菌肽表达。
临床怎么用
- ARG1通路可能作为特应性皮炎等皮肤屏障相关疾病的潜在治疗靶点。
- 补充ARG1下游产物腐胺或尿素可能有助于改善屏障功能。
局限性
- 研究主要基于体外和离体模型,尚未在临床人群中验证。
- 原文未报告样本量、具体统计值和置信区间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arginase 1 (ARG1) is an enzyme expressed by keratinocytes that drives several functions linked to skin barrier function. However, the mechanisms underpinning keratinocyte ARG1 function in barrier homeostasis have not been fully elucidated. Atopic dermatitis (AD) is linked to impaired skin barrier via altered keratinocyte differentiation and susceptibility to infection. OBJECTIVES: To investigate the role of ARG1 in keratinocyte differentiation and antimicrobial responses. METHODS: In vitro two-dimensional differentiation assays using ARG knockdown or ARG inhibited keratinocytes were used to explore the function of ARG1 in keratinocyte differentiation and barrier formation. ARG1 was also assessed in an ex vivo model of AD. RESULTS: ARG1 was strongly expressed in the apical layers of human skin, corresponding to high ARG1 expression in late differentiated -keratinocytes. ARG was downregulated in an ex vivo AD model relative to control, suggesting that altered ARG1 is clinically relevant. ARG1 -inhibition in keratinocytes led to a significant decrease in the late differentiation markers filaggrin, involucrin and loricrin, and significant downregulation of antimicrobial peptides (AMPs), lipocalin 2, kallikreins and small proline-rich proteins. ARG forms part of the urea cycle and the action of ARG on L-arginine causes the production of L-ornithine and urea. In turn, L-ornithine is catabolized for putrescine production. Supplementation with ARG products, putrescine and urea could rescue late keratinocyte differentiation and AMP expression in ARG-deficient cells. CONCLUSIONS: ARG1 activity plays a major role in keratinocyte differentiation and AMP production. ARG1 is downregulated in an AD model, and in cell systems its function can be rescued by the ARG1 downstream products putrescine and urea. Manipulation of the ARG1 pathway may have the potential to be used for the management of skin conditions such as AD. Atopic dermatitis (‘AD’ for short) is a common skin condition. AD causes problems with the skin barrier (known as the ‘epidermis’). These problems can lead to infections that worsen symptoms. A healthy skin barrier involves a balance between cells multiplying (‘proliferating’) and changing their function (‘differentiating’). A key feature of AD is a disruption of this balance. A protein called arginase (or ‘ARG’) could control this process, as it influences skin barrier regulation and damage repair. This study was done in the UK and the Singapore A*STAR Skin Research Labs. It aimed to investigate the role of ARG in the skin barrier. We examined the function of ARG using laboratory techniques and analysing human skin samples. The largest amount of ARG was found in the top layers of human skin. In culture, the amount of ARG increased as the skin cells changed function. A larger amount of ARG increased the amount of some other proteins that help protect the upper layers of the skin barrier. ARG also increased the amount of antimicrobial proteins in the skin. Together, this suggests that ARG is involved in how the skin barrier works and its defence against microbes. Importantly, cells without ARG activity worked normally. This study identifies a role for ARG in the antimicrobial function of skin and promoting the differentiation of skin barrier cells. As the amount of ARG produced in people with AD is less, controlling the activity of ARG might help in the treatment of AD.
引用
- Szondi DC, Crompton RA, Oon L, et al. A role for arginase in skin epithelial differentiation and antimicrobial peptide production. Br J Dermatol. 2025. PMID: 39950979. doi:10.1093/bjd/ljaf057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。